---
title: "GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229894716.md"
description: "According to the Zhitong Finance APP, GEMPHARMATECH released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year"
datetime: "2025-02-27T10:23:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229894716.md)
  - [en](https://longbridge.com/en/news/229894716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229894716.md)
generator: "portal-rs"
---

# GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%

According to the Zhitong Finance APP, GEMPHARMATECH (688046.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year

### Related Stocks

- [688046.CN](https://longbridge.com/en/quote/688046.CN.md)

## Related News & Research

- [04:03 ETDizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026](https://longbridge.com/en/news/296585269.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [China NMPA clears InnoCare Phase III trial of mesutoclax-azacitidine in treatment-naive AML](https://longbridge.com/en/news/296164458.md)
- [CBOT wheat lower as war-fueled rally peters out](https://longbridge.com/en/news/296261143.md)
- [Invo Fertility highlights retrospective IVF platelet-rich plasma studies at Midwest Reproductive Symposium 2026](https://longbridge.com/en/news/296495699.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**